Life Sciences
41 to 50 of 107
-
Article
Submitted: 03 November 2011
In a dramatic and important decision the UK Supreme Court has overturned a decision of the Court of Appeal, by holding that Human Genome Science’s patent for Neutrokine-α has the requisite industrial applicability.
-
Newsletter
Last Reviewed: 26 October 2011 / Submitted: 26 October 2011
October 2011 review of legal and general developments affecting the Life Sciences sector.
-
Article
Last Reviewed: 06 October 2011 / Submitted: 06 October 2011
A look at the approach different jurisdictions are taking over who might constitute a “public official” in the sphere of corporate compliance
-
Video Podcast
Submitted: 13 September 2011
Simmons & Simmons non contentious life sciences specialist Richard Binns talks to colleague Paul England about the issues to look out for if you are seeking to renegotiate or dispute agreements in your patent licence portfolio.
-
Cross Border Guide
Submitted: 05 September 2011
Knowing how to respond to a dawn raid in an informed and efficient manner is an essential part of an organisation's risk management policies. This guide provides detailed information on dawn raids across a range of jurisidiction.
-
Video Podcast
Submitted: 28 July 2011
Simmons & Simmons lawyer Cherie Spinks talks to colleague David Bridge about the issues that have arisen for businesses dealing with the UK and EU sanctions regimes relating to Libya.
-
Newsletter
Last Reviewed: 25 July 2011 / Submitted: 25 July 2011
July 2011 review of legal and general developments affecting the Life Sciences sector.
-
Article
Last Reviewed: 06 July 2011 / Submitted: 06 July 2011
This article considers the difficulties of applying the SPC regime to medicines comprising combination products.
-
Article
Last Reviewed: 16 June 2011 / Submitted: 16 June 2011
The Government`s further consultation on the UK patent box contains some welcome extensions to the scope of the regime offering a 10 per cent rate of tax on profits from patents, but equally indicates that calculating the amount of profits that fall within the regime may be challenging and administratively burdensome.
-
Article
Last Reviewed: 04 May 2011 / Submitted: 04 May 2011
The UK OFT has confirmed the terms of the settlement reached with Reckitt Benckiser to resolve the abuse of dominance case relating to Gaviscon - but a private damages action against the pharma company is already underway.
41 to 50 of 107